Login to Your Account

UK Bioscience Gets $62M to Bridge Valley of Death

By Cormac Sheridan
Staff Writer

Monday, November 5, 2012

Twenty-two UK life sciences companies and a further 10 academic groups will share £39 million (US$62.3 million) in research funding in the largest grant allocation that the Biomedical Catalyst scheme has made to date.

The initiative, which will provide £180 million to accelerate UK life sciences projects over three years, is administered jointly by the Technology Strategy Board (TSB), the UK's innovation agency, and the Medical Research Council.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription